查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1959896

可吸收神經導管市場－全球產業規模、佔有率、趨勢、機會、預測：按材料、應用、給藥方法、地區和競爭對手分類，2021-2031年

Absorbable Nerve Conduits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material, By Application, By Delivery Method, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球可吸收神經導管市場預計將從 2025 年的 48.9 億美元成長到 2031 年的 66.9 億美元，複合年成長率為 5.36%。

這些可生物分解的管狀植入旨在橋接斷裂的周邊神經，促進軸突再生，無需二次切除手術。市場成長的主要促進因素是創傷性損傷病例的增加，以及臨床上越來越傾向於使用合成替代物而非自體移植，以避免供體部位的併發症。例如，世界衛生組織（WHO）在2024年報告稱，道路交通事故每年將造成2,000萬至5,000萬例非致命性損傷，這將持續推動全球對有效神經修復解決方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 48.9億美元
市場規模：2031年 66.9億美元
複合年成長率：2026-2031年 5.36%
成長最快的細分市場 脊髓修復
最大的市場 北美洲

儘管存在這些市場促進因素，但由於現有裝置在填充長段神經缺損方面存在生物學局限性，市場仍面臨許多障礙。導管通常僅限於治療短段缺損，且隨著長度增加，再生效果會顯著下降。這一限制迫使外科醫生在處理大面積神經損傷時依賴傳統的自體移植，從而縮小了合成材料的潛在市場。

市場促進因素

周邊神經損傷和創傷發生率的不斷上升，使得人們迫切需要有效的外科手術來恢復感覺和運動功能，這成為推動市場成長的重要因素。高能量事故，例如車禍和職場，常常導致複雜的神經斷裂，這些斷裂在張力作用下難以修復，對橋接裝置產生了持續的需求。這些創傷事件的規模確保了需要神經修復的患者數量源源不絕。根據美國國家安全委員會 (NSC) 對 2025 年 10 月的初步估計，當年上半年車禍死亡人數達到 18,720 人，這凸顯了高能量創傷對全球醫療保健系統帶來的持續負擔與嚴重神經損傷之間的直接關聯。

同時，自體移植的臨床缺陷正在加速合成替代品的需求。儘管自體神經移植仍然是傳統的標準方法，但供體部位併發症的風險、移植物的獲取難度以及手術時間長等限制因素，正促使外科醫生擴大採用可吸收神經導管。這種向現成解決方案的轉變，在專業市場參與者的強勁財務表現中得到了清晰的體現。例如，Axogen公司在2025年5月公佈的第一季營收為4,860萬美元，較去年同期成長17.4%，這主要得益於其神經修復產品組合的廣泛應用。這項商業性成功也得到了主要醫療設備製造商的支持；Integra Life Sciences公司在2025年2月宣布，其2024年全年銷售額為16.1億美元，這進一步印證了組織技術市場的龐大規模。

市場挑戰

全球可吸收神經導管市場面臨的主要障礙是這些裝置在處理大面積神經缺損時固有的生物學限制。雖然可吸收導管在短距離修復中有效，但對於超過3公分的缺損，它們往往無法提供軸突再生所需的結構支撐和細胞誘導。這項限制迫使醫療專業人員依賴自體或異體神經移植，儘管存在併發症風險，但自體或異體神經移植仍然是長距離修復的黃金標準，這極大地限制了合成導管在複雜創傷病例中的應用。

這種功能上的限制直接影響了市場滲透率。由於功能恢復不良的風險較高，外科醫師往往不願意使用合成材料來治療嚴重的、直徑較大的神經損傷。因此，目標市場僅限於輕微損傷，商業性擴張停滯不前。根據美國整形外科醫師協會的官方日誌，2024 年的一項重組手術趨勢分析顯示，在某些患者群體中，神經管的使用率從 60% 大幅下降至 54.7%。這是由於外科醫生越來越傾向於採用其他方法來修復複雜的神經缺損。這種下降趨勢凸顯了當前市場面臨的困境：在生物學療效的挑戰得到解決之前，市場無法佔據複雜神經重組手術這一高價值領域。

市場趨勢

微創外科技術的應用正在從根本上重塑市場格局，解決了傳統顯微縫合術的技術難題。外科醫生擴大選擇無縫機械固定裝置，以縮短手術時間並降低修復過程中神經上皮損傷的風險。這一趨勢推動了現成纏繞式解決方案的研發，這些方案無需顯微外科重組那樣複雜的技術操作，即可確保神經殘端的穩定對齊，從而擴大了門診神經修復手術的應用範圍。這些技術的快速商業性顯而易見。在2025年9月發布的一份關於其神經修復產品組合擴展的新聞稿中，BioCircuit Technologies公司報告稱，其無縫線「神經膠帶」（Nerve Tape）裝置自上市以來僅16個月就完成了超過3500例植入，凸顯了臨床對簡化輸送系統的巨大需求。

同時，3D生物列印技術在個人化神經植入領域的應用，正推動著具有精準內部結構的支架的研發，這些支架可根據每位患者的具體情況量身定做。這項技術使製造商能夠設計出帶有微通道的導管，這些微通道能夠模擬原始的束狀結構，超越了簡單的中空管，並為較長損傷部位的軸突再生提供更優異的物理引導。透過客製化導管的形狀和孔隙率以適應損傷部位，3D生物列印旨在克服標準合成移植物在功能再生方面的限制。近期研究突顯了這項潛力。 2025年5月發表在bioRxiv上的一項題為「用於無生物材料神經再生的3D列印神經引導導管」的研究表明，實驗性水凝膠基微圖案導管在植入17週後，其運動神經回復率與自體移植相當，證明了結構最佳化設計的有效性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球可吸收神經導管市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依材質（天然材料、合成材料、複合材料）
    • 依應用領域（周邊神經修復、脊髓修復、顱神經修復）
    • 依給藥方式（開放性手術、內視鏡手術、顯微手術）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美可吸收神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲可吸收神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區可吸收神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲可吸收神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲可吸收神經導管市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球可吸收神經導管市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Integra LifeSciences Corporation
  • Medtronic plc
  • CelestRay Biotech Company, LLC
  • Salvia BioElectronics BV
  • Axogen Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27652

The Global Absorbable Nerve Conduits Market is projected to expand from USD 4.89 Billion in 2025 to USD 6.69 Billion by 2031, reflecting a CAGR of 5.36%. These biodegradable tubular implants are designed to bridge defects in severed peripheral nerves, enabling axonal regeneration without necessitating secondary surgeries for removal. Market growth is primarily driven by the rising prevalence of traumatic injuries and a growing clinical preference for synthetic alternatives over autografts to avoid donor site morbidity. For instance, the World Health Organization reported in 2024 that road traffic crashes cause between 20 and 50 million non-fatal injuries annually, generating a sustained global demand for effective nerve repair solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.89 Billion
Market Size 2031USD 6.69 Billion
CAGR 2026-20315.36%
Fastest Growing SegmentSpinal Cord Repair
Largest MarketNorth America

Despite these drivers, the market encounters significant hurdles due to the biological limitations of current devices in bridging long nerve gaps. Conduits are generally restricted to treating short defects, as the consistency of regeneration diminishes notably with increased length. This limitation compels surgeons to rely on traditional autografts for extensive nerve injuries, thereby narrowing the potential addressable market for synthetic options.

Market Driver

The increasing incidence of peripheral nerve injuries and trauma acts as a crucial volume driver for the market, creating a need for effective surgical interventions to restore sensory and motor functions. High-energy accidents, such as vehicular collisions and workplace incidents, often result in complex nerve severances that cannot be repaired under tension, establishing a persistent demand for bridging devices. The magnitude of these traumatic events ensures a steady influx of patients requiring nerve repair. According to the National Safety Council, preliminary estimates in October 2025 showed that motor-vehicle deaths reached 18,720 in the first six months of the year, a statistic that highlights the ongoing high-impact trauma burden on global healthcare systems and its direct correlation with severe nerve injuries.

Concurrently, the clinical drawbacks of autografts are accelerating the demand for synthetic alternatives. Although autologous nerve grafts remain the traditional standard, they are limited by donor site morbidity, scarce graft availability, and longer operative times, prompting surgeons to increasingly adopt absorbable nerve conduits. This shift toward off-the-shelf solutions is evident in the strong financial performance of specialized market players. For example, Axogen, Inc. reported in May 2025 that its first-quarter revenue reached $48.6 million, a 17.4% increase over the previous year, driven by the broad adoption of its nerve repair portfolio. This commercial viability is further validated by larger medtech companies; Integra LifeSciences reported full-year 2024 revenues of $1.61 billion in February 2025, confirming the substantial market scale for tissue technologies.

Market Challenge

The primary obstacle hindering the Global Absorbable Nerve Conduits Market is the inherent biological restriction of these devices when addressing extensive nerve defects. While effective for short-distance repairs, absorbable conduits often fail to provide the necessary structural support and cellular guidance required for axonal regeneration across gaps exceeding three centimeters. This limitation forces medical professionals to rely on autologous nerve grafts or allografts, which remain the gold standard for long-gap repairs despite their associated morbidity, thereby severely capping the adoption rate of synthetic conduits in complex trauma cases.

This functional ceiling directly negatively impacts market penetration, as surgeons are hesitant to utilize synthetic options for critical, large-diameter nerve injuries due to the heightened risk of poor functional recovery. Consequently, the addressable market is confined to minor injuries, stalling broader commercial expansion. According to the American Society of Plastic Surgeons' official journal, in 2024, an analysis of reconstruction trends indicated that nerve conduit utilization had effectively decreased from 60% to 54.7% in specific cohorts as surgeons increasingly pivoted toward alternatives for challenging defects. This decline underscores the market's inability to capture the high-value segment of complex nerve reconstruction surgeries until these biological efficacy hurdles are resolved.

Market Trends

The application of minimally invasive surgical delivery techniques is fundamentally reshaping the market by addressing the technical complexities associated with traditional microsuturing. Surgeons are increasingly gravitating toward sutureless mechanical coaptation devices that reduce operative time and mitigate the risk of trauma to the nerve epineurium during repair. This trend is driving the development of off-the-shelf, wrap-based solutions that ensure consistent alignment of nerve stumps without the steep learning curve of microsurgical reconstruction, thereby expanding the adoption of nerve repair procedures in outpatient settings. The rapid commercial uptake of such technologies is evident; according to BioCircuit Technologies, September 2025, in a press release regarding the expansion of its nerve repair portfolio, the company reported that over 3,500 of its sutureless Nerve Tape devices had been implanted within just 16 months of commercialization, underscoring the high clinical demand for simplified delivery systems.

Simultaneously, the adoption of 3D bioprinting for personalized nerve implants is advancing the development of scaffolds with precise, patient-specific internal architectures. This technology enables manufacturers to move beyond simple hollow tubes and engineer conduits with defined microchannels that mimic the native fascicular structure, providing superior physical guidance for regenerating axons across longer defects. By customizing the conduit's geometry and porosity to match the specific injury site, 3D bioprinting aims to overcome the functional regeneration limits of standard synthetic grafts. This potential was highlighted in recent research; according to a study published in bioRxiv, May 2025, titled '3D Printed Nerve Guidance Conduit for Biologics-Free Nerve Regeneration,' experimental hydrogel-based micro-patterned conduits demonstrated functional motor nerve recovery rates on par with autografts after a 17-week implantation period, validating the efficacy of architecturally optimized designs.

Key Market Players

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Integra LifeSciences Corporation
  • Medtronic plc
  • CelestRay Biotech Company, LLC
  • Salvia BioElectronics B.V.
  • Axogen Corporation

Report Scope

In this report, the Global Absorbable Nerve Conduits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Absorbable Nerve Conduits Market, By Material

  • Natural Material
  • Synthetic Material
  • Composite Material

Absorbable Nerve Conduits Market, By Application

  • Peripheral Nerve Repair
  • Spinal Cord Repair
  • Cranial Nerve Repair

Absorbable Nerve Conduits Market, By Delivery Method

  • Open Surgery
  • Endoscopic Surgery
  • Microscopic Surgery

Absorbable Nerve Conduits Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Absorbable Nerve Conduits Market.

Available Customizations:

Global Absorbable Nerve Conduits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Absorbable Nerve Conduits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Material (Natural Material, Synthetic Material, Composite Material)
    • 5.2.2. By Application (Peripheral Nerve Repair, Spinal Cord Repair, Cranial Nerve Repair)
    • 5.2.3. By Delivery Method (Open Surgery, Endoscopic Surgery, Microscopic Surgery)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Absorbable Nerve Conduits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Material
    • 6.2.2. By Application
    • 6.2.3. By Delivery Method
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Absorbable Nerve Conduits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Material
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Delivery Method
    • 6.3.2. Canada Absorbable Nerve Conduits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Material
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Delivery Method
    • 6.3.3. Mexico Absorbable Nerve Conduits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Material
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Delivery Method

7. Europe Absorbable Nerve Conduits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Material
    • 7.2.2. By Application
    • 7.2.3. By Delivery Method
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Absorbable Nerve Conduits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Material
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Delivery Method
    • 7.3.2. France Absorbable Nerve Conduits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Material
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Delivery Method
    • 7.3.3. United Kingdom Absorbable Nerve Conduits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Material
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Delivery Method
    • 7.3.4. Italy Absorbable Nerve Conduits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Material
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Delivery Method
    • 7.3.5. Spain Absorbable Nerve Conduits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Material
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Delivery Method

8. Asia Pacific Absorbable Nerve Conduits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Material
    • 8.2.2. By Application
    • 8.2.3. By Delivery Method
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Absorbable Nerve Conduits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Material
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Delivery Method
    • 8.3.2. India Absorbable Nerve Conduits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Material
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Delivery Method
    • 8.3.3. Japan Absorbable Nerve Conduits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Material
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Delivery Method
    • 8.3.4. South Korea Absorbable Nerve Conduits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Material
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Delivery Method
    • 8.3.5. Australia Absorbable Nerve Conduits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Material
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Delivery Method

9. Middle East & Africa Absorbable Nerve Conduits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Material
    • 9.2.2. By Application
    • 9.2.3. By Delivery Method
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Absorbable Nerve Conduits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Material
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Delivery Method
    • 9.3.2. UAE Absorbable Nerve Conduits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Material
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Delivery Method
    • 9.3.3. South Africa Absorbable Nerve Conduits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Material
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Delivery Method

10. South America Absorbable Nerve Conduits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Material
    • 10.2.2. By Application
    • 10.2.3. By Delivery Method
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Absorbable Nerve Conduits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Material
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Delivery Method
    • 10.3.2. Colombia Absorbable Nerve Conduits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Material
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Delivery Method
    • 10.3.3. Argentina Absorbable Nerve Conduits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Material
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Delivery Method

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Absorbable Nerve Conduits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. B. Braun Melsungen AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Integra LifeSciences Corporation
  • 15.4. Medtronic plc
  • 15.5. CelestRay Biotech Company, LLC
  • 15.6. Salvia BioElectronics B.V.
  • 15.7. Axogen Corporation

16. Strategic Recommendations

17. About Us & Disclaimer